Where does Fred Eshelman work?

Fred Eshelman is Founder at Eshelman Ventures, LLC and Board director at Innocrin Pharmaceuticals Holdings and Board director at Hyperion Defi and Board director at Dignify Therapeutics.

What boards does Fred Eshelman sit on?

Fred Eshelman holds tracked board seats at Dignify Therapeutics, Hyperion Defi, Innocrin Pharmaceuticals Holdings, Neoantigenics.

Fred Eshelman

Investor

Founder at Eshelman Ventures, LLC · Board director at Innocrin Pharmaceuticals Holdings · Board director at Hyperion Defi · Board director at Dignify Therapeutics

Wilmington, North Carolina, United States

About

Founder of Eshelman Ventures who typically serves on the boards of portfolio companies. He previously founded and led Pharmaceutical Product Development (PPD, NASDAQ) as CEO and Executive Chairman before the company was sold to private equity.

Contact· self-published, not guessed

f•••@eshelmanventures.comreveal

Board director at Innocrin Pharmaceuticals Holdings

Intro paths

→

In turn, Fred can intro founders to Innocrin Pharmaceuticals Holdings's investors below.

Innocrin Pharmaceuticals Holdings's investors · 1

Eshelman Ventures, LLCWilmington · since 2015

Board director at Hyperion Defi

Intro paths

→

In turn, Fred can intro founders to Hyperion Defi's investors below.

Hyperion Defi's investors · 2

Eshelman Ventures, LLCWilmington · since 2016 TullisPalm Beach Gardens · since 2020

Board director at Dignify Therapeutics

Intro paths

→

In turn, Fred can intro founders to Dignify Therapeutics's investors below.

Dignify Therapeutics's investors · 3

Eshelman Ventures, LLCWilmington · since 2014 National Institutes of Health (NIH)since 2015 RA CapitalBoston

Co-founders at Dignify Therapeutics

Karl B ThorExecutive Officer, Director, Promoter

Edward C BurgardExecutive Officer, Director, Promoter

Karl Thor

Experience

Furiex Pharmaceuticalschairman
Eshelman Ventures LLCprincipalcurrent2014 — presentwilmington nc

Deals · 18

Hyperion DefiBoard seat

via Eshelman Ventures, LLC · filed Aug 2016 · $8M raise

Innocrin Pharmaceuticals HoldingsBoard seat

via Eshelman Ventures, LLC · filed Apr 2015 · $28.1M raise

NeoantigenicsBoard seat

via Eshelman Ventures, LLC · filed Feb 2015 · $3M raise

Incyclix BioSolo GP

via Eshelman Ventures, LLC · filed Aug 2025

Dignify TherapeuticsSolo GP

via Eshelman Ventures, LLC · filed Feb 2015 · $3.4M raise

Aruna BioSolo GP

via Eshelman Ventures, LLC

Breakthru MedicineSolo GP

via Eshelman Ventures, LLC

CarbonSolo GP

via Eshelman Ventures, LLC

Cavalry BiosciencesSolo GP

via Eshelman Ventures, LLC

GenesisSolo GP

via Eshelman Ventures, LLC

Jupiter BioventuresSolo GP

via Eshelman Ventures, LLC

Komo BiosciencesSolo GP

via Eshelman Ventures, LLC

Med AditusSolo GP

via Eshelman Ventures, LLC

Paradigm TherapeuticsSolo GP

via Eshelman Ventures, LLC

Phoenix Molecular DesignsSolo GP

via Eshelman Ventures, LLC

Sapience TherapeuticsSolo GP

via Eshelman Ventures, LLC

Wilmington Design Co.Solo GP

via Eshelman Ventures, LLC

Auven TherapeuticsSolo GP

via Eshelman Ventures, LLC

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Colleagues at Eshelman Ventures, LLC

Ashley Miller

Investor at Eshelman Ventures, LLC

Nan Howard

Investor at Eshelman Ventures, LLC

Frequently asked questions

Who is Fred Eshelman?: Founder of Eshelman Ventures who typically serves on the boards of portfolio companies. He previously founded and led Pharmaceutical Product Development (PPD, NASDAQ) as CEO and Executive Chairman before the company was sold to private equity.
Where does Fred Eshelman work?: Fred Eshelman is Founder at Eshelman Ventures, LLC and Board director at Innocrin Pharmaceuticals Holdings and Board director at Hyperion Defi and Board director at Dignify Therapeutics.
What boards does Fred Eshelman sit on?: Fred Eshelman holds tracked board seats at Dignify Therapeutics, Hyperion Defi, Innocrin Pharmaceuticals Holdings, Neoantigenics.